Search research articles
Contact Us
Filters
Showing results (781-790 of 1,466) with videos related to
Page
of 147
Sort By:
Circulation
|
March 1, 1991
Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators
G B Habib, J Heibig, S A Forman, et al.
Leukemia
|
July 20, 2007
Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif
B Falini, E Albiero, N Bolli, et al.
Stem Cell Reviews and Reports
|
October 29, 2020
Comparison of One and Three Intraventricular Injections of Cardiac Progenitor Cells in a Murine Model of Chronic Ischemic Cardiomyopathy
Yiru Guo, Yibing Nong, Qianhong Li, et al.
Diabetes, Obesity & Metabolism
|
June 30, 2017
Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4)
Philip D Home, Richard M Bergenstal, Geremia B Bolli, et al.
Current Hypertension Reports
|
June 14, 2014
The role of adiponectin in endothelial dysfunction and hypertension
Edward Rojas, Daloha Rodríguez-Molina, Peter Bolli, et al.
Diabetes, Obesity & Metabolism
|
February 3, 2015
New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)
G B Bolli, M C Riddle, R M Bergenstal, et al.
The Journal of Nutrition
|
November 14, 1997
Nicotinamide counteracts alcohol-induced impairment of hepatic protein metabolism in humans
E Volpi, P Lucidi, G Cruciani, et al.
Basic Research in Cardiology
|
April 26, 2015
Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling
Anindita Das, Fadi N Salloum, Scott M Filippone, et al.
Diabetes Care
|
June 19, 2015
New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)
Philip D Home, Richard M Bergenstal, Geremia B Bolli, et al.
Diabetes
|
October 28, 2003
Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans
Francesca Porcellati, Simone Pampanelli, Paolo Rossetti, et al.
Page
of 147
Search research articles
Search
Showing results (781-790 of 1,466) with videos related to
Sort By:
Page
of 147
Circulation
|
March 1, 1991
Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators
G B Habib, J Heibig, S A Forman, et al.
Leukemia
|
July 20, 2007
Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif
B Falini, E Albiero, N Bolli, et al.
Stem Cell Reviews and Reports
|
October 29, 2020
Comparison of One and Three Intraventricular Injections of Cardiac Progenitor Cells in a Murine Model of Chronic Ischemic Cardiomyopathy
Yiru Guo, Yibing Nong, Qianhong Li, et al.
Diabetes, Obesity & Metabolism
|
June 30, 2017
Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4)
Philip D Home, Richard M Bergenstal, Geremia B Bolli, et al.
Current Hypertension Reports
|
June 14, 2014
The role of adiponectin in endothelial dysfunction and hypertension
Edward Rojas, Daloha Rodríguez-Molina, Peter Bolli, et al.
Diabetes, Obesity & Metabolism
|
February 3, 2015
New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)
G B Bolli, M C Riddle, R M Bergenstal, et al.
The Journal of Nutrition
|
November 14, 1997
Nicotinamide counteracts alcohol-induced impairment of hepatic protein metabolism in humans
E Volpi, P Lucidi, G Cruciani, et al.
Basic Research in Cardiology
|
April 26, 2015
Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling
Anindita Das, Fadi N Salloum, Scott M Filippone, et al.
Diabetes Care
|
June 19, 2015
New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)
Philip D Home, Richard M Bergenstal, Geremia B Bolli, et al.
Diabetes
|
October 28, 2003
Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans
Francesca Porcellati, Simone Pampanelli, Paolo Rossetti, et al.
Page
of 147